Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does UNSPECIFIED INGREDIENT Cause Neoplasm malignant? 77 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 77 reports of Neoplasm malignant have been filed in association with UNSPECIFIED INGREDIENT. This represents 0.3% of all adverse event reports for UNSPECIFIED INGREDIENT.

77
Reports of Neoplasm malignant with UNSPECIFIED INGREDIENT
0.3%
of all UNSPECIFIED INGREDIENT reports
16
Deaths
14
Hospitalizations

How Dangerous Is Neoplasm malignant From UNSPECIFIED INGREDIENT?

Of the 77 reports, 16 (20.8%) resulted in death, 14 (18.2%) required hospitalization, and 1 (1.3%) were considered life-threatening.

Is Neoplasm malignant Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for UNSPECIFIED INGREDIENT. However, 77 reports have been filed with the FAERS database.

What Other Side Effects Does UNSPECIFIED INGREDIENT Cause?

Death (2,090) Off label use (1,306) Drug ineffective (1,227) Completed suicide (1,190) Nausea (1,041) Fatigue (1,020) Dyspnoea (934) Pneumonia (903) Asthenia (894) Vomiting (877)

What Other Drugs Cause Neoplasm malignant?

RANITIDINE (10,648) ADALIMUMAB (2,028) APIXABAN (1,772) ETANERCEPT (1,616) METHOTREXATE (1,041) TOFACITINIB (1,020) RITUXIMAB (929) INFLIXIMAB (892) ABATACEPT (727) RISANKIZUMAB-RZAA (715)

Which UNSPECIFIED INGREDIENT Alternatives Have Lower Neoplasm malignant Risk?

UNSPECIFIED INGREDIENT vs UPADACITINIB UNSPECIFIED INGREDIENT vs URAPIDIL UNSPECIFIED INGREDIENT vs UREA UNSPECIFIED INGREDIENT vs URIDINE TRIACETATE UNSPECIFIED INGREDIENT vs UROFOLLITROPIN

Related Pages

UNSPECIFIED INGREDIENT Full Profile All Neoplasm malignant Reports All Drugs Causing Neoplasm malignant UNSPECIFIED INGREDIENT Demographics